These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25815756)

  • 61. An open-label safety and pharmacokinetics study of duloxetine in pediatric patients with major depression.
    Prakash A; Lobo E; Kratochvil CJ; Tamura RN; Pangallo BA; Bullok KE; Quinlan T; Emslie GJ; March JS
    J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):48-55. PubMed ID: 22251023
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Delirium and multiple electrolyte abnormalities associated with high dose paroxetine exposure.
    Chuang YF; Chiu YL; Hwang TJ; Chu TS
    Psychiatry Clin Neurosci; 2006 Oct; 60(5):642-3. PubMed ID: 16958954
    [No Abstract]   [Full Text] [Related]  

  • 63. Should children take antidepressants?
    Harv Ment Health Lett; 2003 Dec; 20(6):5-7. PubMed ID: 14690974
    [No Abstract]   [Full Text] [Related]  

  • 64. Sexual function during long-term duloxetine treatment in patients with recurrent major depressive disorder.
    Montejo AL; Perahia DG; Spann ME; Wang F; Walker DJ; Yang CR; Detke MJ
    J Sex Med; 2011 Mar; 8(3):773-82. PubMed ID: 21091877
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and tolerability of controlled-release paroxetine.
    Golden RN
    Psychopharmacol Bull; 2003; 37 Suppl 1():176-86. PubMed ID: 14566210
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Increases in amplitude of low-frequency fluctuations in left fronto-parietal area after duloxetine therapy in first-episode, drug-naïve, major depressive disorder with panic disorder patients.
    Lai CH
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):E24-5. PubMed ID: 23037667
    [No Abstract]   [Full Text] [Related]  

  • 67. [Restless legs syndrome in patients on dialysis for kidney insufficiency: effect of medication].
    Hohl-Radke F; Aedtner F; Domröse U; Neumann KH; Staedt J
    Dtsch Med Wochenschr; 2008 Jan; 133(3):71-5. PubMed ID: 18186007
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A probable case of movement disorder (Tardive dyskinesia) due to duloxetine treatment.
    Yılmaz R; Üstün D; Tuncer Uzun S; Reisli R; Türk Ş
    Agri; 2018 Oct; 30(4):199-201. PubMed ID: 30403275
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Duloxetine-Associated Acute Laryngeal Dystonia: A Case Report.
    Dagklis IE; Rokkou I; Kazis D; Bostantjopoulou S
    J Clin Psychopharmacol; 2019; 39(6):678-679. PubMed ID: 31688398
    [No Abstract]   [Full Text] [Related]  

  • 70. Duloxetine and gingival bleeding: a case-report and reviews of the French and World PharmacoVigilance Databases and literature.
    Gicquel C; Moulis F; Chenaf C; Gouraud A; Drici M; Bondon-Guitton E; Montastruc F; Montastruc JL
    Eur J Clin Pharmacol; 2017 Sep; 73(9):1197-1198. PubMed ID: 28639120
    [No Abstract]   [Full Text] [Related]  

  • 71. Excessive sweating induced by interaction between agomelatine and duloxetine hydrochloride: case report and review of the literature.
    Štuhec M
    Wien Klin Wochenschr; 2015 Sep; 127(17-18):703-6. PubMed ID: 25576334
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Acute Urinary Retention and Acute Kidney Injury After Duloxetine Treatment: A Rare Case Report.
    Aktürk Esen S; Gül CB; Kahvecioğlu S; Aktaş N; Esen İ
    J Clin Psychopharmacol; 2019; 39(3):279-281. PubMed ID: 30908353
    [No Abstract]   [Full Text] [Related]  

  • 73. Transitory restless arms syndrome in a patient with antipsychotics and antidepressants: a case report.
    Chen J; Meng N; Cao B; Ye Y; Ou Y; Li Z
    BMC Psychiatry; 2021 Sep; 21(1):453. PubMed ID: 34530775
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel treatments for major depressive disorder.
    Lydiard RB
    CNS Spectr; 2009 Mar; 14(3 Suppl 5):11-3. PubMed ID: 19407718
    [No Abstract]   [Full Text] [Related]  

  • 75. Galactorrhea with normal prolactin levels associated with duloxetine.
    Demirci S; Unubol M; Demirci K
    J Clin Psychopharmacol; 2015 Jun; 35(3):346-7. PubMed ID: 25756878
    [No Abstract]   [Full Text] [Related]  

  • 76. Toxic hepatitis associated with paroxetine.
    Colakoglu O; Tankurt E; Unsal B; Ugur F; Kupelioglu A; Buyrac Z; Akpinar Z
    Int J Clin Pract; 2005 Jul; 59(7):861-2. PubMed ID: 15963219
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Isn't It About Time to Employ Measurement-Based Care in Practice?
    Rush AJ
    Am J Psychiatry; 2015 Oct; 172(10):934-6. PubMed ID: 26315984
    [No Abstract]   [Full Text] [Related]  

  • 78. Both paroxetine and imipramine appear to be ineffective in adolescents with major depression, furthermore doubts have risen about their safety.
    Birkenhager TK
    Evid Based Med; 2016 Jun; 21(3):92. PubMed ID: 26887424
    [No Abstract]   [Full Text] [Related]  

  • 79. Data mining approach shows promise in detecting unexpected drug interactions.
    Hampton T
    JAMA; 2011 Jul; 306(2):144. PubMed ID: 21750287
    [No Abstract]   [Full Text] [Related]  

  • 80. Serum levels of substance P and response to antidepressant pharmacotherapy.
    Lieb K; Walden J; Grunze H; Fiebich BL; Berger M; Normann C
    Pharmacopsychiatry; 2004 Sep; 37(5):238-9. PubMed ID: 15470802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.